Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Interventional, Post-Marketing Surveillance Phase IV Study to Asses the Efficacy and Safety of Telmisartan, With the Special Attention on the Influence of Telmisartan on Selected Metabolic Parameters of Patients

NCT00471003 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00471003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00471003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Interventional, Post-Marketing Surveillance Phase IV Study to Asses the Efficacy and Safety of Telmisartan, With the Special Attention on the Influence of Telmisartan on Selected Metabolic Parameters of Patients
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
September 30, 2006
Completion date
November 30, 2009
Enrollment
5,448 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension